Transcription of IPV guidelines ecbs1 - WHO
{{id}} {{{paragraph}}}
ENGLISH ONLY EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Geneva, 17 to 21 February 2003 guidelines FOR THE SAFE PRODUCTION AND QUALITY CONTROL OF IPV MANUFACTURED FROM WILD POLIOVIRUSES BIOSAFETY LEVEL 3/POLIO NOTE: This document has been prepared for the purpose of inviting comments and suggestions on the proposals contained therein, and for the preparation of the materials to be considered by the Expert Committee on Biological Standardization. The text in its present form does not necessarily represent an agreed formulation of the Expert Committee. Comments proposing modifications to this text MUST be received by 31 January 2003 and should be addressed to the World Health Organization, 1211 Geneva 27, Switzerland, attention: Quality Assurance and Safety of Biologicals (QSB). Addendum to WHO Recommendations for the Production and Quality Control of Poliomyelitis Vaccine (Inactivated) The WHO Recommendations for Production and Quality Control of Poliomyelitis Vaccine (Inactivated) were last revised in 2000.
bs/03.1951 english only expert committee on biological standardization geneva, 17 to 21 february 2003 guidelines for the safe production …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Unit 3 Policies and Procedures, Unit 3 – Policies and Procedures, Policies and procedures, Licensing Review Handbook, North Dakota, Policies and procedures: Identity theft prevention, Policies and procedures: Identity theft prevention and, Procedures, And Procedures, INSTITUTIONAL REVIEW, Governing, Policies, Procedures for obtaining informed consent for, PROCEDURES for obtaining informed consent for recordings, Quality Control Best Practices, Freddie Mac, Quality Control Best Practices Quality Control Best Practices